Guilong Zhao

Title: The Innovations of Guilong Zhao

Introduction

Guilong Zhao is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of urate transporter inhibitors. With a total of seven patents to his name, Zhao's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents is a crystal form of urate transporter 1 inhibitor and its preparation method and use. This invention provides a stable crystal form that enhances the purity and storage stability of the compound, making it suitable as a pharmaceutical raw material. Another notable patent is a method for preparing a URAT1 inhibitor, specifically 2-((5-bromo-4-((4-bromonaphthalen-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio) acetic acid. This method is characterized by its low cost, ease of handling, and applicability to industrialization, representing a significant advancement over prior art.

Career Highlights

Guilong Zhao has worked at the Tianjin Institute of Pharmaceutical Research and the Tianjin Institute of Pharmaceutical Research Co., Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Zhao has collaborated with notable colleagues such as Weiren Xu and Lida Tang, contributing to a dynamic research environment that fosters innovation and development in the pharmaceutical sector.

Conclusion

Guilong Zhao's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments and pharmaceutical development.